Macy's Inc. (M) Rises 0.23% After Earnings

2026-06-03 · Stocks · QuoteReporter

Post Earning Analysis

Macy's Inc. (M) Rises 0.23% After Earnings

Macy's, Inc. operates as a retailer offering a wide range of consumer goods including apparel, cosmetics, and home furnishings through its Macy's, Bloomingdale's, and Bluemercury brands. The current investment case for Macy's is a "hold" due to the challenging retail environment, which poses significant risks to near-term growth and profitability.

Macy's has posted its strongest first-quarter growth in four years and has raised its full-year guidance, signaling a robust recovery and defying broader consumer market concerns. This development is particularly significant as it marks the fourth consecutive quarter of sales gains for the retailer, a clear indication of effective strategic initiatives under CEO Tony Spring. The upward revision of the full-year outlook not only reflects Macy's resilience in a fluctuating retail environment but also suggests a sustainable turnaround that could potentially recalibrate market expectations for the company's performance.

Investors should consider this a bullish signal for Macy's stock in the near term. The consistent upward trajectory in quarterly results and the optimistic full-year guidance could lead to increased investor confidence and potentially higher stock valuations. The market might still be underpricing Macy's ability to maintain this momentum amidst economic uncertainties, which presents a buying opportunity.

The next significant catalyst for Macy's will be the upcoming quarterly earnings announcement. This event will be crucial for confirming the sustainability of the current growth trajectory and for providing further insights into the company's long-term strategy under the ongoing leadership of CEO Tony Spring.

The current price of the stock is $22.12, marking an increase of $0.23 today. The Relative Strength Index (RSI) stands at 66.06, suggesting that the stock is approaching overbought territory but still has some room before a potential reversal. The Moving Average Convergence Divergence (MACD) at 0.76 indicates positive momentum, supporting the likelihood of continued upward movement in the short term.

Comparing the current price to moving averages, the stock is trading above its 50-day and 200-day moving averages by 13.68% and 14.74%, respectively, signaling a healthy uptrend. The stock's price is near the upper end of its 52-week range, currently 7.68% below the 52-week high of $23.96 and significantly above the low of $10.23.

This price action and positioning relative to key technical indicators suggest that market sentiment is currently positive towards this stock, with investors likely expecting further gains.

Dividend Payments Table

The dividend profile of the company shows a pattern of consistent growth. Over the past two years, the quarterly dividend has increased from $0.174 to $0.192. This represents a growth rate from the dividend paid in March 2024 to that in March 2026, indicating a commitment to increasing shareholder returns.

The incremental increases, particularly the recent rise from $0.182 to $0.192, suggest a positive outlook by management regarding the company’s financial health and cash flow capabilities. This is a good signal for income investors, as it reflects both stability and a potential for continued income growth.

Comparing this dividend growth to alternative investments, such as the 10-year Treasury yield, the company's dividend yield, coupled with its growth, may present a more attractive option for income-focused portfolios. The consistent increase in dividends, without any cuts or irregularities, enhances its appeal to investors looking for reliable and potentially growing income streams.

The most recent Wall Street ratings for the stock in question show a mix of opinions, reflecting a divided sentiment among analysts. On March 19, 2026, Telsey Advisory Group reiterated a "Market Perform" rating but lowered their target price from $25 to $20. Earlier, on January 14, 2026, Jefferies resumed coverage with a "Buy" rating and set a target price of $27. Guggenheim initiated coverage on December 10, 2025, with a "Neutral" rating, though they did not specify a target price. Lastly, on December 4, 2025, Telsey Advisory Group reiterated a "Market Perform" rating, raising their target from $22 to $25.

The consensus among these analysts suggests a cautious outlook, with target prices ranging from $20 to $27. The most bullish outlook comes from Jefferies with a $27 target, while the most bearish, from Telsey Advisory Group, recently adjusted their target to $20. Given the range of target prices and the mixed ratings, the market sentiment appears divided, with no strong consensus on the stock's future direction.

Investors should consider whether the current stock price reflects these varied opinions. If the stock is trading near the lower end of these targets, there might be upside potential, particularly if Jefferies' bullish stance holds weight. Conversely, if the price is near the higher target, caution may be warranted. Given the lack of a strong consensus, investors might want to look for additional fundamental analysis or market developments before aligning with the most bullish or bearish views. Trusting the consensus might be risky without a clearer directional signal from the market or the company's performance.

With a current price of $22.12 and a consensus target of $27 from Jefferies, the stock presents a potential upside of +22%. This gap suggests that the market may be undervaluing the stock, especially considering the bullish stance from a major analyst despite recent price target adjustments by Telsey Advisory Group.

The earnings per share (EPS) and dividend trends are not detailed here, but the significant potential upside indicated by the target price suggests that these financial metrics might be aligning well with a growth trajectory, supporting the valuation story.

The market might be underpricing the company's resilience or growth prospects, possibly due to overemphasis on the recent negative adjustment by Telsey, which could be a reactionary move rather than indicative of long-term performance.

A critical forward catalyst will be the next quarterly earnings report. Should the company meet or exceed expectations, it would likely validate the bullish perspective and could lead to a reevaluation of the stock's potential, pushing it closer to or beyond the $27 target. Conversely, underperformance would lend weight to the more cautious views and could see the stock adjust downwards, aligning more closely with Telsey's revised target.

Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.